title: Serum lipid levels in pregnancies complicated by preeclampsia.
abstract: OBJECTIVE
  Pre-eclampsia is a disorder that occurs only during pregnancy. Postpartum changes relating to lipid metabolism may contribute towards the endothelial lesions observed in preeclampsia. Thus, the aim of the present study was to evaluate the lipid profile among patients who present preeclampsia and correlate these parameters with 24-hour proteinuria.
  
  
  METHODS
  Cross-sectional analytical study including 77 pregnant patients seen at Hospital Dório Silva.
  
  
  METHODS
  This study involved 42 women with preeclampsia and 35 healthy pregnant women in the third trimester of pregnancy as controls. Blood samples were obtained from all the patients, and the serum levels of triglycerides, total cholesterol, low-density lipoproteins (LDL), high-density lipoproteins (HDL) and very low density lipoproteins (VLDL) were determined. Cases and controls were matched for maternal age, gestational week and body mass index.
  
  
  RESULTS
  The VLDL and triglyceride values from the women with preeclampsia were significantly higher than those of the healthy women. There was a positive correlation between increased proteinuria and higher VLDL and triglyceride levels in patients with preeclampsia.
  
  
  CONCLUSIONS
  Among the patients with preeclampsia, higher VLDL and triglyceride levels were positively correlated with proteinuria. These observations indicate that the pregnant women who presented elevated lipid levels were more susceptible to cardiovascular disorders and, consequently, pre-eclampsia.
authors: Obstetrics Department, Universidade Federal de São Paulo, Brazil. valmirlima.es@uol.com.br
authors: Valmir Jose de
authors: VJ
authors: Lima
authors: Claudia Roberta de
authors: CR
authors: Andrade
authors: Gustavo Enrico
authors: GE
authors: Ruschi
authors: Nelson
authors: N
authors: Sass
references: BJOG. 2006 Apr;113(4):379-86
references: 16553649
references: Arq Bras Cardiol. 2001 Nov;77 Suppl 3:1-48
references: 11781591
references: Lancet. 1999 Sep 4;354(9181):788-9
references: 10485715
references: J Clin Lipidol. 2007 May;1(2):104-41
references: 21291675
references: Obstet Gynecol. 2002 Jan;99(1):159-67
references: 16175681
references: Clin Sci. 1955 Feb;14(1):15-23
references: 14364836
references: Indian J Physiol Pharmacol. 2009 Oct-Dec;53(4):365-9
references: 20509330
references: Obstet Gynecol. 2001 Apr;97(4):533-8
references: 11275024
references: J Lipid Res. 1996 Feb;37(2):299-308
references: 9026528
references: J Clin Endocrinol Metab. 2000 Dec;85(12):4543-50
references: 11134106
references: Obstet Gynecol Surv. 2007 Feb;62(2):117-24
references: 17229328
references: Lancet. 2001 Jan 6;357(9249):53-6
references: 11197372
references: Acta Endocrinol (Copenh). 1971 Jul;67(3):570-6
references: 5108736
references: J Reprod Med. 1973 Mar;10(3):95-101
references: 4348501
references: N Engl J Med. 1999 Jan 14;340(2):115-26
references: 9887164
references: J Clin Endocrinol Metab. 2003 Mar;88(3):1162-6
references: 12629100
references: Lancet. 2000 Oct 7;356(9237):1260-5
references: 11072961
references: Hypertens Pregnancy. 2006;25(1):3-10
references: 16613787
references: Metabolism. 1998 Oct;47(10):1281-8
references: 9781635
references: Am J Obstet Gynecol. 1996 Mar;174(3):975-82
references: 8633679
references: Obstet Gynecol. 1997 Mar;89(3):403-8
references: 9052594
references: Lancet. 2005 Nov 19;366(9499):1797-803
references: 16298217
references: BMJ. 2007 Nov 10;335(7627):974
references: 17975258